Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 17

Zeitschriftenartikel

Holzgreve, Adrien; Potter, Dennis; Brendel, Matthias; Orth, Michael; Weidner, Lorraine; Gold, Lukas; Kirchner, Maximilian A.; Bartos, Laura M.; Unterrainer, Lena M.; Unterrainer, Marcus; Steiger, Katja; Baumgarten, Louisa von; Niyazi, Maximilian; Belka, Claus; Bartenstein, Peter; Riemenschneider, Markus J.; Lauber, Kirsten und Albert, Nathalie L. (2022): Longitudinal [F-18]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model. In: Biomedicines, Bd. 10, Nr. 4 [PDF, 2MB]

Orth, Michael; Albrecht, Valerie; Seidl, Karin; Kinzel, Linda; Unger, Kristian; Hess, Julia; Kreutzer, Lisa; Sun, Na; Stegen, Benjamin; Nieto, Alexander; Maas, Jessica; Winssinger, Nicolas; Friedl, Anna A.; Walch, Axel K.; Belka, Claus; Zitzelsberger, Horst; Niyazi, Maximilian und Lauber, Kirsten (17. März 2021): Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond. In: Frontiers in Oncology, Bd. 11, 612354 [PDF, 13MB]

Vounotrypidis, Efstathios; Hillenmayer, Anna; Wertheimer, Christian M.; Athanasiou, Alexis; Siedlecki, Jakob; Orth, Michael; Ohlmann, Andreas; Priglinger, Siegfried G. und Wolf, Armin (2021): In vitro evaluation of simulated stereotactic radiotherapy for wet age-related macular degeneration on three different cell lines. In: Scientific Reports, Bd. 11, Nr. 1, 8068

Schoetz, Ulrike; Klein, Diana; Hess, Julia; Shnayien, Seyd; Spoerl, Steffen; Orth, Michael; Mutlu, Samet; Hennel, Roman; Sieber, Anja; Ganswindt, Ute; Luka, Benedikt; Thomsen, Andreas R.; Unger, Kristian; Jendrossek, Verena; Zitzelsberger, Horst; Bluethgen, Nils; Belka, Claus; Unkel, Steffen; Klinger, Bertram und Lauber, Kirsten (2021): Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. In: Cell Death & Disease, Bd. 12, Nr. 12, 1162

Mahajan, Ujjwal M.; Li, Qi; Alnatsha, Ahmed; Maas, Jessica; Orth, Michael; Maier, Sebastian Hubertus; Peterhansl, Julian; Regel, Ivonne; Sendler, Matthias; Wagh, Preshit R.; Mishra, Neha; Xue, Yonggan; Allawadhi, Prince; Beyer, Georg; Kuehn, Jens-Peter; Marshall, Thomas; Appel, Bettina; Laemmerhirt, Felix; Belka, Claus; Mueller, Sabine; Weiss, Frank-Ulrich; Lauber, Kirsten; Lerch, Markus M. und Mayerle, Julia (2021): Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models. In: Gastroenterology, Bd. 161, Nr. 3: S. 996-1010

Schoetz, Ulrike; Klein, Diana; Hess, Julia; Shnayien, Seyd; Spoerl, Steffen; Orth, Michael; Mutlu, Samet; Hennel, Roman; Sieber, Anja; Ganswindt, Ute; Luka, Benedikt; Thomsen, Andreas R.; Unger, Kristian; Jendrossek, Verena; Zitzelsberger, Horst; Blüthgen, Nils; Belka, Claus; Unkel, Steffen; Klinger, Bertram und Lauber, Kirsten ORCID logoORCID: https://orcid.org/0000-0002-8141-0452 (2021): Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma. In: Cell death & disease, Bd. 12, 1162 [PDF, 5MB]

Stegen, Benjamin; Nieto, Alexander; Albrecht, Valerie; Maas, Jessica; Orth, Michael; Neumaier, Klement; Reinhardt, Sabine; Weick-Kleemann, Moritz; Goetz, Wilfried; Reinhart, Merle; Parodi, Katia; Belka, Claus; Niyazi, Maximilian und Lauber, Kirsten (2020): Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study. In: Radiation Oncology, Bd. 15, Nr. 1, 19

Gennen, Kathrin; Kaesmann, Lukas; Taugner, Julian; Eze, Chukwuka; Karin, Monika; Roengvoraphoj, Olarn; Neumann, Jens; Tufman, Amanda; Orth, Michael; Reu, Simone; Belka, Claus und Manapov, Farkhad (2020): Prognostic value of PD-L1 expression on tumor cells combined with CD8+TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. In: Radiation Oncology, Bd. 15, Nr. 1, 5

Krombach, Julia; Hennel, Roman; Brix, Nikko; Orth, Michael; Schoetz, Ulrike; Ernst, Anne; Schuster, Jessica; Zuchtriegel, Gabriele; Reichel, Christoph A.; Bierschenk, Susanne; Sperandio, Markus; Vogl, Thomas; Unkel, Steffen; Belka, Claus und Lauber, Kirsten (2019): Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells. In: Oncoimmunology, Bd. 8, Nr. 1, e1523097

Orth, Michael; Metzger, Philipp; Gerum, Sabine; Mayerle, Julia; Schneider, Guenter; Belka, Claus; Schnurr, Maximilian und Lauber, Kirsten (2019): Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. In: Radiation Oncology, Bd. 14, Nr. 1, 141

Jin, Xi-Feng; Auernhammer, Christoph J.; Ilhan, Harun; Lindner, Simon; Nolting, Svenja; Maurer, Julian; Spottl, Gerald und Orth, Michael (2019): Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro. In: Journal of Nuclear Medicine, Bd. 60, Nr. 9: S. 1240-1246

Fankhauser, Maria; Bechmann, Nicole; Lauseker, Michael; Goncalves, Judith; Favier, Judith; Klink, Barbara; William, Doreen; Gieldon, Laura; Maurer, Julian; Spöttl, Gerald; Rank, Petra; Knösel, Thomas; Orth, Michael; Ziegler, Christian G.; Aristizabal Prada, Elke Tatjana; Rubinstein, German; Fassnacht, Martin; Spitzweg, Christine; Grossman, Ashley B.; Pacak, Karel; Beuschlein, Felix; Bornstein, Stefan R.; Eisenhofer, Graeme; Auernhammer, Christoph J.; Reincke, Martin und Nölting, Svenja (2019): Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures. In: Endocrinology, Bd. 160, Nr. 11: S. 2600-2617

Aristizabal Prada, Elke Tatjana; Weis, Carla; Orth, Michael; Lauseker, Michael; Spöttl, Gerald; Maurer, Julian; Grabowski, Patricia; Grossman, Ashley; Auernhammer, Christoph Josef und Nölting, Svenja (2. Oktober 2018): GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors? In: Neuroendocrinology, Bd. 106, Nr. 4: S. 335-351

Prada, Elke Tatjana Aristizabal; Orth, Michael; Nölting, Svenja; Spöttl, Gerald; Maurer, Julian und Auernhammer, Christoph (2017): The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
In: PLOS One 12(5), e0178375 [PDF, 15MB]

Hess, Julia; Unger, Kristian; Orth, Michael; Schötz, Ulrike; Schüttrumpf, Lars; Zangen, Verena; Gimenez-Aznar, Igor; Michna, Agata; Schneider, Ludmila; Stamp, Ramona; Selmansberger, Martin; Braselmann, Herbert; Hieber, Ludwig; Drexler, Guido A.; Kuger, Sebastian; Klein, Diana; Jendrossek, Verena; Friedl, Anna A.; Belka, Claus; Zitzelsberger, Horst und Lauber, Kirsten (2017): Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance. In: Cancer Letters, Bd. 386: S. 87-99

Kinzel, Linda; Ernst, Anne; Orth, Michael; Albrecht, Valerie; Hennel, Roman; Brix, Nikko; Frey, Benjamin; Gaipl, Udo S.; Zuchtriegel, Gabriele; Reichel, Christoph A.; Blutke, Andreas; Schilling, Daniela; Multhoff, Gabriele; Li, Minglun; Niyazi, Maximilian; Friedl, Anna A.; Winssinger, Nicolas; Belka, Claus und Lauber, Kirsten (2016): A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer. In: Oncotarget, Bd. 7, Nr. 28: S. 43199-43219

Hocke, Sandra; Guo, Yang; Job, Albert; Orth, Michael; Ziesch, Andreas; Lauber, Kirsten; De Toni, Enrico N.; Gress, Thomas M.; Herbst, Andreas; Göke, Burkhard und Gallmeier, Eike (2016): A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers. In: Oncotarget, Bd. 7, Nr. 6: S. 7080-7095

Diese Liste wurde am Sat Mar 23 21:29:03 2024 CET erstellt.